Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Market Performance Gen Digital Inc. Contingent Value Rights (NASDAQ:GENVR) surged 5.1% in today's trading, closing at $1.64. The Technology stock traded 182.3822 shares, below its…
Read moreMarket Performance GraniteShares 2x Short COIN Daily ETF (NASDAQ:CONI) surged 5.1% in today's trading, closing at $51.49. The Financial Services stock traded 136,619 shares, below…
Read moreMarket Performance Churchill Capital Corp IX (NASDAQ:CCIXU) surged 5.1% in today's trading, closing at $11.56. The Financial Services stock traded 349 shares, 3.3x its average…
Read moreMarket Performance Currenc Group, Inc. (NASDAQ:CURR) surged 5.1% in today's trading, closing at $2.90. The Financial Services stock traded 48,122 shares, below its average daily…
Read moreMarket Performance SM Energy Company (NYSE:SM) surged 5.1% in today's trading, closing at $29.34. The Energy stock traded 3,969,517 shares, above its average daily volume of…
Read moreMarket Performance HF Sinclair Corporation (NYSE:DINO) surged 5.1% in today's trading, closing at $77.69. The Energy stock traded 1,464,024 shares, below its average daily volume…
Read moreMarket Performance T-Rex 2X Long NVIDIA Daily Target ETF (BATS:NVDX) surged 5.0% in today's trading, closing at $17.27. The Financial Services stock traded 7,779,732 shares, below…
Read moreMarket Performance Methanex Corporation (NASDAQ:MEOH) surged 5.0% in today's trading, closing at $48.25. The Basic Materials stock traded 1,309,156 shares, 2.7x its average daily…
Read moreRating Change Stifel analysts reiterated a Buy rating on Ligand Pharmaceuticals, Inc. (OTC:LGNDZ) on July 08, 2026. Market Context Ligand Pharmaceuticals, Inc.
Read moreRating Change Stifel analysts reiterated a Buy rating on Ligand Pharmaceuticals, Inc. (OTC:LGNZZ) on July 08, 2026. Market Context Ligand Pharmaceuticals, Inc.
Read moreRating Change Raymond James analysts upgraded Tvardi Therapeutics, Inc. (NASDAQ:TVRD) from Market Perform to Outperform on July 08, 2026. Market Context Tvardi Therapeutics, Inc.
Read moreRating Change Jefferies analysts reiterated a Buy rating on Atlanticus Holdings Corporation (NASDAQ:ATLCP) on July 08, 2026. Market Context Atlanticus Holdings Corporation…
Read moreRating Change Jefferies analysts reiterated a Buy rating on Atlanticus Holdings Corporation 6.125% Senior Notes due 2026 (NASDAQ:ATLCL) on July 08, 2026. Market Context Atlanticus…
Read moreRating Change Jefferies analysts reiterated a Buy rating on Atlanticus Holdings Corporation 9.25% Senior Notes due 2029 (NASDAQ:ATLCZ) on July 08, 2026. Market Context Atlanticus…
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on MGP Ingredients, Inc. (NASDAQ:MGPI) on July 08, 2026. Market Context MGP Ingredients, Inc.
Read moreRating Change Stephens & Co. analysts initiated coverage on Covenant Logistics Group, Inc. (NASDAQ:CVLG) with a Overweight rating on July 08, 2026.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Assurant, Inc. 5.25% Subordinat (NYSE:AIZN) on July 08, 2026. Market Context Assurant, Inc.
Read moreRating Change JP Morgan analysts initiated coverage on BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) with a Overweight rating on July 08, 2026. Market Context BridgeBio…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on AXIS Capital Holdings Limited (NYSE:AXS) on July 08, 2026. Market Context AXIS Capital Holdings…
Read moreRating Change Barclays analysts initiated coverage on MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) with a Overweight rating on…
Read more
